ELMD

Electromed, Inc. [ELMD] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

ELMD Stock Summary

Top ELMD Correlated Resources

ELMD


Top 10 Correlated ETFs

ELMD


Top 10 Correlated Stocks

ELMD


In the News

11:07 28 Mar 2024 ELMD

Electromed: Blowout Quarter, Beneficial 2024 Guidance, And Cheap

Electromed reported an impressive quarter and expects beneficial results for 2024, with a total market opportunity of 4.2 million Bronchiectasis patients. The company's growth strategies, including direct-to-consumer marketing and internationalization efforts, could drive significant net sales growth. Electromed's stock repurchase program and recent price dynamics make it an attractive investment opportunity.

10:18 28 Mar 2024 ELMD

Electromed, Inc. (ELMD) Q2 2024 Earnings Call Transcript

Electromed, Inc. (ELMD) Q2 2024 Earnings Call Transcript

10:55 28 Mar 2024 ELMD

Electromed, Inc. (ELMD) Q1 2024 Earnings Call Transcript

Electromed, Inc. (NYSE:ELMD ) Q1 2024 Results Conference Call November 7, 2023 5:00 PM ET Company Participants Mike Cavanaugh - IR, ICR Westwicke Jim Cunniff - President and CEO Brad Nagel - CFO Conference Call Participants Aaron Wukmir - Lake Street Capital Markets Operator Good day, and welcome to the Electromed First Quarter 2024 Earnings Conference Call. [Operator Instructions] Please note today's event is being recorded.

01:25 28 Mar 2024 ELMD

Electromed: May Reversal Vindicating Long-Term Buy Thesis

Electromed continues to rally off previous lows and crossed above the 50DMA last week. SmartVest numbers are ratcheting higher, CMS waiver decision well priced into the equity level.

05:32 28 Mar 2024 ELMD

Electromed, Inc. (ELMD) Q3 2023 Earnings Call Transcript

Electromed, Inc. (NYSE:ELMD ) Q3 2023 Results Conference Call May 9, 2023 5:00 PM ET Company Participants Mike Cavanaugh - Investor Relations Kathleen Skarvan - President and Chief Executive Officer Brad Nagel - Chief Financial Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Operator Welcome to the Electromed Third Quarter Fiscal 2023 Financial Results Conference Call [Operator Instructions]. I will now turn the call over to your host, Mike Cavanaugh, Investor Relations.

04:21 28 Mar 2024 ELMD

Electromed, Inc. Schedules its Third Quarter Fiscal 2023 Financial Results Conference Call for May 9, 2023 at 5:00 p.m. ET

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Schedules its Third Quarter Fiscal 2023 Financial Results Conference Call for May 9, 2023 at 5:00 p.m. ET.

11:37 28 Mar 2024 ELMD

Electromed: Reiterating Buy With Sales Rep Conversions Driving Top-Line Growth

Solid Q2 result with upsides versus consensus at the top and bottom lines. Sales force increase converting to further sales growth with >$950,000 in revenue/rep this quarter.

08:19 28 Mar 2024 ELMD

Electromed, Inc. (ELMD) Q2 2023 Earnings Call Transcript

Electromed, Inc. (NYSE:ELMD ) Q2 2023 Earnings Conference Call February 14, 2023 5:00 PM ET Company Participants Mike Cavanaugh – Investor Relations Kathleen Skarvan – President and Chief Executive Officer Brad Nagel – Chief Financial Officer Conference Call Participants Brooks O'Neil – Lake Street Operator Greetings, and welcome to Electromed's Fiscal Second Quarter Earnings Call. At this time all participants are in a listen-only mode.

09:00 28 Mar 2024 ELMD

Electromed: SmartVest Clearance Adds Alpha Opportunity, Rate Buy

Received 510(K) clearance for its SmartVest system last month. Meaningful alpha opportunity in helping patients with complex respiratory disorders, large addressable market.

11:19 28 Mar 2024 ELMD

Electromed, Inc. (ELMD) Q1 2023 Earnings Call Transcript

Electromed, Inc. (NYSE:ELMD ) Q1 2023 Earnings Conference Call November 8, 2022 5:00 PM ET Company Participants Mike Cavanaugh - IR Kathleen Skarvan - CEO & President Michelle Wirtz - Interim CFO Conference Call Participants Operator Hello, and welcome to the Electromed Fiscal First Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode.

ELMD Financial details

Company Rating
Buy
Market Cap
148.27M
Income
3.94M
Revenue
51.69M
Book val./share
4.72
Cash/share
1.22
Dividend
-
Dividend %
-
Employees
170
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
27.64
Forward P/E
41.03
PEG
3.73
P/S
1.81
P/B
2.34
P/C
13.45
P/FCF
76.81
Quick Ratio
5.37
Current Ratio
6.27
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.47
EPS next Y
0.4
EPS next Q
0.13
EPS this Y
37.04%
EPS next Y
-14.89%
EPS next 5Y
-14.89%
EPS last 5Y
9.04%
Revenue last 5Y
8.96%
Revenue Q/Q
11.08%
EPS Q/Q
900%
-
-
-
-
SMA20
13.33%
SMA50
70%
SMA100
70%
Inst Own
23.18%
Inst Trans
0.86%
ROA
7%
ROE
9%
ROC
0.11%
Gross Margin
76%
Oper. Margin
8%
Profit Margin
7%
Payout
-
Shs Outstand
8.61M
Shs Float
6.14M
-
-
-
-
Target Price
-
52W Range
8.8-17.85
52W High
-3.47%
52W Low
+105.13%
RSI
58
Rel Volume
0.55
Avg Volume
29.14K
Volume
16.05K
Perf Week
-6.81%
Perf Month
21.83%
Perf Quarter
56.88%
Perf Half Y
59.01%
-
-
-
-
Beta
0.423
-
-
Volatility
0.39%, 1.01%
Prev Close
0%
Price
16.41
Change
0.31%

ELMD Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-06-30

Metric History 2019-06-302020-06-302021-06-302022-06-30 2023-06-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
3.773.864.174.925.68
Net income per share
0.240.50.280.270.37
Operating cash flow per share
0.310.50.36-0.080.16
Free cash flow per share
0.140.380.31-0.26-0.05
Cash per share
0.941.251.390.960.87
Book value per share
3.13.63.784.034.45
Tangible book value per share
3.033.533.713.964.38
Share holders equity per share
3.13.63.784.034.45
Interest debt per share
-0.010.01000.01
Market cap
43.91M129.33M96.71M81.66M90.65M
Enterprise value
36.15M118.93M84.91M73.55M83.44M
P/E ratio
22.331.0840.9535.4328.63
Price to sales ratio
1.43.982.71.961.89
POCF ratio
16.9530.8231.43-119.0468.93
PFCF ratio
36.5540.1736.79-36.94-226.05
P/B Ratio
1.714.282.982.392.41
PTB ratio
1.714.282.982.392.41
EV to sales
1.153.662.371.771.74
Enterprise value over EBITDA
9.6620.3122.6420.4318.06
EV to operating cash flow
13.9628.3427.6-107.2263.45
EV to free cash flow
30.0936.9432.3-33.27-208.07
Earnings yield
0.040.030.020.030.03
Free cash flow yield
0.030.020.03-0.030
Debt to equity
00000
Debt to assets
00000
Net debt to EBITDA
-2.07-1.78-3.15-2.25-1.56
Current ratio
6.789.386.834.834.69
Interest coverage
-31.0700118.880
Income quality
1.321.011.3-0.30.42
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
0.020.030.050.030.02
Intangibles to total assets
0.020.020.020.010.01
Capex to operating cash flow
-0.54-0.23-0.152.22-1.3
Capex to revenue
-0.04-0.03-0.01-0.04-0.04
Capex to depreciation
-1.5-1.32-0.73-2.43-2.8
Stock based compensation to revenue
0.030.030.030.020.01
Graham number
4.076.334.854.976.12
ROIC
0.070.130.070.070.08
Return on tangible assets
0.070.130.060.060.07
Graham Net
1.92.332.492.192.34
Working capital
20.92M25.04M27.07M27.39M29.73M
Tangible asset value
25.15M29.65M31.75M33.57M37.06M
Net current asset value
20.92M25.03M27.01M27.35M29.65M
Invested capital
00000
Average receivables
12.66M13.93M15.77M19.38M22.98M
Average payables
698.61K571.04K620.26K973K1.32M
Average inventory
2.49M2.85M2.6M2.65M3.7M
Days sales outstanding
160.41158.56177.88186.96186.93
Days payables outstanding
28.7327.8929.5945.0543.37
Days of inventory on hand
128.43154.8591.3113.53133.41
Receivables turnover
2.282.32.051.951.95
Payables turnover
12.713.0912.348.18.42
Inventory turnover
2.842.3643.212.74
ROE
0.080.140.070.070.08
Capex per share
-0.17-0.12-0.05-0.18-0.2

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q2

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.391.431.61.441.6
Net income per share
0.120.130.120.020.2
Operating cash flow per share
0.160.080.12-0.030.41
Free cash flow per share
0.110.010.07-0.040.4
Cash per share
0.820.80.870.821.22
Book value per share
4.194.34.434.484.72
Tangible book value per share
4.124.234.354.414.65
Share holders equity per share
4.194.34.434.484.72
Interest debt per share
-0.0200.0300
Market cap
88.57M88M91.16M88.7M93.23M
Enterprise value
81.66M81.22M83.95M81.68M82.79M
P/E ratio
22.6620.4722.06143.0713.92
Price to sales ratio
7.557.296.77.26.81
POCF ratio
64.93136.2291.25-363.5426.86
PFCF ratio
98.081000163.37-235.2927.55
P/B Ratio
2.512.422.422.322.31
PTB ratio
2.512.422.422.322.31
EV to sales
6.966.736.176.636.05
Enterprise value over EBITDA
64.162.5349.82229.4433.49
EV to operating cash flow
59.87125.7384.03-334.7523.85
EV to free cash flow
90.43923150.45-216.6624.47
Earnings yield
0.010.010.0100.02
Free cash flow yield
0.0100.0100.04
Debt to equity
00000
Debt to assets
00000
Net debt to EBITDA
-5.42-5.22-4.28-19.73-4.22
Current ratio
5.685.484.696.275.97
Interest coverage
-7.41-467.400
Income quality
1.40.60.97-1.572.07
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
0.010.010.020.020.01
Intangibles to total assets
0.010.010.010.010.01
Capex to operating cash flow
-0.34-0.86-0.440.55-0.03
Capex to revenue
-0.04-0.05-0.03-0.01-0.01
Capex to depreciation
-2.79-5.42-2.31-0.62-0.42
Stock based compensation to revenue
0.020.020.010.030.03
Graham number
3.33.513.481.354.56
ROIC
0.030.030.0300.04
Return on tangible assets
0.020.030.0200.04
Graham Net
2.272.292.332.512.79
Working capital
28.15M28.75M29.73M30.42M32.69M
Tangible asset value
34.77M35.79M37.06M37.61M39.73M
Net current asset value
28.12M28.72M29.65M30.35M32.64M
Invested capital
00000
Average receivables
21.8M22.6M23.88M24.31M23.78M
Average payables
1.03M1.04M1.33M1.21M1.05M
Average inventory
3.57M3.46M3.84M4.35M4.62M
Days sales outstanding
169.29172.53162.76175.26154.91
Days payables outstanding
23.1938.5239.0533.6629.8
Days of inventory on hand
102.58103.12120.14142.68136.26
Receivables turnover
0.530.520.550.510.58
Payables turnover
3.882.342.32.673.02
Inventory turnover
0.880.870.750.630.66
ROE
0.030.030.0300.04
Capex per share
-0.05-0.07-0.05-0.02-0.01

ELMD Frequently Asked Questions

What is Electromed, Inc. stock symbol ?

Electromed, Inc. is a US stock , located in New prague of Mn and trading under the symbol ELMD

What is Electromed, Inc. stock quote today ?

Electromed, Inc. stock price is $16.41 today.

Is Electromed, Inc. stock public?

Yes, Electromed, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap